4.7 Article

Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease

Related references

Note: Only part of the references are listed.
Article Clinical Neurology

ELECTROMYOGRAPHIC FINDINGS IN 37 PATIENTS WITH ADULT-ONSET ACID MALTASE DEFICIENCY

Charles D. Kassardjian et al.

MUSCLE & NERVE (2015)

Article Biochemistry & Molecular Biology

Recovery of altered neuromuscular junction morphology and muscle function in mdx mice after injury

Stephen J. P. Pratt et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2015)

Article Biochemistry & Molecular Biology

Peripheral nerve and neuromuscular junction pathology in Pompe disease

Darin J. Falk et al.

HUMAN MOLECULAR GENETICS (2015)

Article Biotechnology & Applied Microbiology

Sustained Correction of Motoneuron Histopathology Following Intramuscular Delivery of AAV in Pompe Mice

Mai K. ElMallah et al.

MOLECULAR THERAPY (2014)

Article Biotechnology & Applied Microbiology

A Chaperone Enhances Blood α-Glucosidase Activity in Pompe Disease Patients Treated With Enzyme Replacement Therapy

Giancarlo Parenti et al.

MOLECULAR THERAPY (2014)

Article Medicine, Research & Experimental

B-cell depletion is protective against anti-AAV capsid immune response: a human subject case study

M. Corti et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2014)

Article Biochemistry & Molecular Biology

Site-specific Mtm1 mutagenesis by an AAV-Cre vector reveals that myotubularin is essential in adult muscle

Romain Joubert et al.

HUMAN MOLECULAR GENETICS (2013)

Article Biotechnology & Applied Microbiology

Intrapleural Administration of AAV9 Improves Neural and Cardiorespiratory Function in Pompe Disease

Darin J. Falk et al.

MOLECULAR THERAPY (2013)

Review Pediatrics

Pompe Disease: Early Diagnosis and Early Treatment Make a Difference

Yin-Hsiu Chien et al.

PEDIATRICS AND NEONATOLOGY (2013)

Article Biotechnology & Applied Microbiology

Preclinical Toxicology and Biodistribution Studies of Recombinant Adeno-Associated Virus 1 Human Acid α-Glucosidase

Thomas J. Conlon et al.

HUMAN GENE THERAPY CLINICAL DEVELOPMENT (2013)

Editorial Material Cell Biology

Impaired autophagy contributes to muscle atrophy in glycogen storage disease type II patients

Anna Chiara Nascimbeni et al.

AUTOPHAGY (2012)

Article Cell Biology

Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models

James J. Dowling et al.

DISEASE MODELS & MECHANISMS (2012)

Article Biotechnology & Applied Microbiology

Spinal Delivery of AAV Vector Restores Enzyme Activity and Increases Ventilation in Pompe Mice

Kai Qiu et al.

MOLECULAR THERAPY (2012)

Article Biochemical Research Methods

Icy: an open bioimage informatics platform for extended reproducible research

Fabrice de Chaumont et al.

NATURE METHODS (2012)

Review Biochemistry & Molecular Biology

Pompe disease gene therapy

Barry J. Byrne et al.

HUMAN MOLECULAR GENETICS (2011)

Article Biochemistry & Molecular Biology

Separation of Fast from Slow Anabolism by Site-specific PEGylation of Insulin-like Growth Factor I (IGF-I)

Friedrich Metzger et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemical Research Methods

Electrical Impedance as a Novel Biomarker of Myotube Atrophy and Hypertrophy

Sergey Rakhilin et al.

JOURNAL OF BIOMOLECULAR SCREENING (2011)

Article Biotechnology & Applied Microbiology

Gel-mediated Delivery of AAV1 Vectors Corrects Ventilatory Function in Pompe Mice With Established Disease

Cathryn S. Mah et al.

MOLECULAR THERAPY (2010)

Article Biotechnology & Applied Microbiology

Rescue of the spinal muscular atrophy phenotype in a mouse model by early postnatal delivery of SMN

Kevin D. Foust et al.

NATURE BIOTECHNOLOGY (2010)

Article Clinical Neurology

Acute Progression of Neuromuscular Findings in Infantile Pompe Disease

T. Andrew Burrow et al.

PEDIATRIC NEUROLOGY (2010)

Article Biotechnology & Applied Microbiology

Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes

Kevin D. Foust et al.

NATURE BIOTECHNOLOGY (2009)

Article Multidisciplinary Sciences

Neural deficits contribute to respiratory insufficiency in Pompe disease

Lara R. DeRuisseau et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Medicine, General & Internal

Adulte Form des Mangels an saurer Maltase unter dem Bild einer progressiven spinalen Muskelatrophie*

D. Pongratz et al.

DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT (2008)

Review Medicine, General & Internal

Lysosomal storage disease 2 - Pompe's disease

Ans T. van der Ploeg et al.

LANCET (2008)

Article Biotechnology & Applied Microbiology

Physiological correction of Pompe disease by systemic delivery of adeno-associated virus serotype 1 vectors

Cathryn Mah et al.

MOLECULAR THERAPY (2007)

Article Endocrinology & Metabolism

Systemic administration of IGF-I enhances oxidative status and reduces contraction-induced injury in skeletal muscles of mdx dystrophic mice

Jonathan D. Schertzer et al.

AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2006)

Article Cell Biology

Tibialis anterior muscles in mdx mice are highly susceptible to contraction-induced injury

C Dellorusso et al.

JOURNAL OF MUSCLE RESEARCH AND CELL MOTILITY (2001)